Last reviewed · How we verify
Magan (magnesium salicylate)
At a glance
| Generic name | magnesium salicylate |
|---|---|
| Drug class | magnesium salicylate |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
- Minor backache pain relief
Common side effects
Drug interactions
- phenprocoumon
- warfarin
Key clinical trials
- IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes (PHASE3)
- Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT) (PHASE4)
- Maximizing Outcomes Needed After Percutaneous Coronary Intervention (PCI) Using Weight Management (MOMENTUM) (NA)
- Topical Piroxicam vs Soulagel in the Treatment of Acute Extremity Pain After Emergency Department Discharge (PHASE2,PHASE3)
- Modulating Glucose Tolerance With Dietary Tyrosine (NA)
- The Impact of Air Travel on Passenger Cognitive Functions (PHASE2,PHASE3)
- Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection (PHASE4)
- Project RAD: A Brief Intervention for Young Adult Alcohol or Marijuana Users (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Magan CI brief — competitive landscape report
- Magan updates RSS · CI watch RSS
- portfolio CI